Adam J. Rish has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Lean Chemometrics in Spectroscopic Process Analytical Technology

    by Adam J. Rish, Samuel R. Henson, Owen Rehrauer

    The adoption of spectroscopy as a process analytical technology (PAT) modality in the pharmaceutical industry and related sectors has enabled advanced monitoring and control of manufacturing processes. Most applications of spectroscopic PAT instruments are dependent on chemometric multivariate data analysis (MVDA) methods to extract the relevant process data from the spectral measurements. However, calibrating and maintaining conventional MVDA methods is often burdensome, as it requires extensive time, material, and financial costs to generate the necessary representative samples and corresponding reference data. This calibration burden can be a barrier to the adoption of spectroscopic PAT in the pharmaceutical industry. Within this article, a classification of MVDA methods referred to as “lean chemometrics” is proposed and formalized. Lean chemometrics are time‐saving, material‐sparing, and cost‐cutting MVDA methods that reduce the calibration burden relative to conventional chemometric methods of choice for spectroscopic PAT. Categories of various MVDA methods that are classifiable as lean chemometric techniques and practical considerations for integration of these techniques with PAT in common pharmaceutical PAT applications are discussed. The intention of lean chemometrics is to raise awareness of solutions that minimize the challenge of calibration burden toward improving spectroscopic PAT adoption.


  • Open Access

    Defining the Range of Calibration Burden: From Full Calibration to Calibration-Free

    by Adam J. Rish, Samuel Henson, James K. Drennen, Carl A. Anderson

    The expansion of spectroscopic process analytical technology (PAT) within the pharmaceutical industry requires chemometric models to enable spectral interpretation. However, calibration of chemometric models often require an intense time, material, and financial burden which may discourage PAT deployment. The advancement of modeling strategies that reduce this calibration burden necessitates consistent terminology for describing model inputs and overall calibration burden throughout chemometric literature. The goal of this article is to define levels of calibration burden by clarifying dataset classifications and model inputs during PAT method development. The scope of this work is specific to calibration of chemometric models incorporated in PAT methods. Harmonizing the language used in the field of chemometrics to describe calibration burden benefits both pharmaceutical manufacturers and regulatory agencies.


  • Diagnostic development using net analyte signal for pure component modeling approaches

    by Adam J. Rish, Natasha L. Velez-Silva, Samuel Henson, Nahid Hasan, James K. Drennen, Carl A. Anderson


  • Strategies for controlling afucosylation in monoclonal antibodies during upstream manufacturing

    by Adam J. Rish, Khandaker Siddiquee, Zhuangrong Huang, Jianlin Xu, Carl A. Anderson, Michael C. Borys, Anurag Khetan

    Core fucosylation is a highly prevalent and significant feature of N‐glycosylation in therapeutic monoclonal antibodies produced by mammalian cells where its absence (afucosylation) plays a key role in treatment safety and efficacy. Notably, even slight changes in the level of afucosylation can have a considerable impact on the antibody‐dependent cell‐mediated cytotoxicity. Therefore, implementing control over afucosylation levels is important in upstream manufacturing to maintain consistent quality across batches of product, since standard downstream processing does not change afucosylation. In this review, the influences and strategies to control afucosylation are presented. In particular, there is emphasis on upstream manufacturing culture parameters and media supplementation, as these offer particular advantages as control strategies over alternative approaches such as cell line engineering and chemical inhibitors. The review discusses the relationship between the afucosylation influences and the underlying cellular metabolism to promote increased process understanding. Also, briefly highlighted is the value of empirical and mechanistic models in evaluating and designing control methods for core fucosylation.


  • Open Access

    Identification of Cell Culture Factors Influencing Afucosylation Levels in Monoclonal Antibodies by Partial Least-Squares Regression and Variable Importance Metrics

    by Adam J. Rish, Zhuangrong Huang, Khandaker Siddiquee, Jianlin Xu, Carl A. Anderson, Michael C. Borys, Anurag Khetan

    Retrospective analysis of historic data for cell culture processes is a powerful tool to develop further process understanding. In particular, deploying retrospective analyses can identify important cell culture process parameters for controlling critical quality attributes, e.g., afucosylation, for the production of monoclonal antibodies (mAbs). However, a challenge of analyzing large cell culture data is the high correlation between regressors (particularly media composition), which makes traditional analyses, such as analysis of variance and multivariate linear regression, inappropriate. Instead, partial least-squares regression (PLSR) models, in combination with machine learning techniques such as variable importance metrics, are an orthogonal or alternative approach to identifying important regressors and overcoming the challenge of a highly covariant data structure. A specific workflow for the retrospective analysis of cell culture data is proposed that covers data curation, PLS regression, model analysis, and further steps. In this study, the proposed workflow was applied to data from four mAb products in an industrial cell culture process to identify significant process parameters that influence the afucosylation levels. The PLSR workflow successfully identified several significant parameters, such as temperature and media composition, to enhance process understanding of the relationship between cell culture processes and afucosylation levels.


  • Metabolic trends of Chinese hamster ovary cells in biopharmaceutical production under batch and fed‐batch conditions

    by Adam J. Rish, James K. Drennen, Carl A. Anderson

    Extensive knowledge of Chinese hamster ovary (CHO) cell metabolism is required to improve process productivity and culture performance in biopharmaceutical manufacturing. However, CHO cells show a dynamic metabolism during culturing in batch and fed‐batch bioreactors. CHO cell metabolism is generally described as taking place in three stages: exponential growth phase, stationary phase, and death phase. This review aims to summarize the trends of central metabolism for CHO cells during each stage. Additional insights into how culture conditions are related to phase transitions and force metabolic rewiring are provided. Understanding of CHO cell metabolism lends itself to improving culture qualities by, for example, identifying sources of toxic byproducts and pathways for cellular engineering. In summary, this review describes the changes in CHO cell central metabolism over the course of the culture.